Research programme: retinoid X receptor alpha agonists - GlaxoSmithKline
Alternative Names: GW 0791; Retinoid X receptor alpha agonists research programme - GlaxoSmithKlineLatest Information Update: 29 Apr 2009
At a glance
- Originator GlaxoSmithKline
- Class
- Mechanism of Action Retinoid X receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 29 Apr 2009 Discontinued - Preclinical for Type-2 diabetes mellitus in USA (unspecified route)
- 19 Apr 2002 Preclinical trials in Type-2 diabetes mellitus in USA (unspecified route)